Fiche publication
Date publication
janvier 2025
Journal
Respiratory medicine
Auteurs
Membres identifiés du Cancéropôle Est :
Pr BONNIAUD Philippe
Tous les auteurs :
Tiotiu A, Migueres N, Gonzalez-Barcala FJ, Roux P, Oster JP, Moutard N, de Blay F, Bonniaud P
Lien Pubmed
Résumé
Patients with severe allergic asthma (SAA) and blood eosinophil count ≥0.3x10/L are eligible for multiple biologics. Several of them showed benefits on nasal polyps (NP), a frequent comorbidity of the severe asthma, but comparative studies on their effectiveness in the association SAA-NP are currently lacking. OUR OBJECTIVE: was to compare the effectiveness of anti-IgE, anti-IL5/R and anti-IL4R in patients with SAA-NP in real-world settings.
Mots clés
biologics, comparative analysis, effectiveness, nasal polyps, severe allergic asthma
Référence
Respir Med. 2025 01 31;:107979
